Mingyi Shang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Extracellular vesicles in disease
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 6
- Circular RNAs in diseases 2
- Extracellular vesicles in disease 2
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 5
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Shaoqiu Wu (13 shared papers)Aiwu Mao (10 shared papers)Bingyan Liu (6 shared papers)Yiping Jia (6 shared papers)Xiang Yin (8 shared papers)Shuo Yan (2 shared papers)Jun Ma (3 shared papers)Jun Ma (2 shared papers)
- Journals
- Cellular Signalling (2 papers)Journal of Cellular Biochemistry (1 paper)American Journal of Cancer Research (1 paper)Journal of Cellular Physiology (1 paper)Cancer Medicine (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Mingyi Shang
21 papers receiving 733 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 425
- Molecular Biology 536
- Immunology 120
- Oncology 135
- Toxicology 12
Countries citing papers authored by Mingyi Shang
This map shows the geographic impact of Mingyi Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyi Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyi Shang more than expected).
Fields of papers citing papers by Mingyi Shang
This network shows the impact of papers produced by Mingyi Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyi Shang. The network helps show where Mingyi Shang may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingyi Shang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 186 | |
| 2 | 2018 | 139 | |
| 3 | 2016 | 62 | |
| 4 | 2016 | 49 | |
| 5 | 1986 | 43 | |
| 6 | 2020 | 38 | |
| 7 | 2018 | 36 | |
| 8 | 2021 | 31 | |
| 9 | 2019 | 24 | |
| 10 | 2020 | 23 | |
| 11 | MiR-4262 promotes cell apoptosis and inhibits proliferation of colon cancer cells: involvement of GALNT4. | 2018 | 23 |
| 12 | 2017 | 18 | |
| 13 | 2018 | 15 | |
| 14 | 2021 | 11 | |
| 15 | 2022 | 11 | |
| 16 | 2020 | 7 | |
| 17 | HP1BP3 promotes tumor growth and metastasis by upregulating miR-23a to target TRAF5 in esophageal squamous cell carcinoma. | 2021 | 7 |
| 18 | 2022 | 6 | |
| 19 | 2021 | 3 | |
| 20 | [Effects of mesenchymal stem cell transplantation on growth of liver cancer: experiment with rats]. | 2009 | 2 |
About Mingyi Shang
Mingyi Shang is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Immunology, having authored 22 papers that have together received 735 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers), Cancer, Hypoxia, and Metabolism (3 papers), Esophageal and GI Pathology (3 papers), Circular RNAs in diseases (2 papers), Extracellular vesicles in disease (2 papers) and Esophageal Cancer Research and Treatment (2 papers). The work is most often cited by research in Cancer Research (425 citations), Molecular Biology (536 citations), Immunology (120 citations), Oncology (135 citations) and Toxicology (12 citations). Mingyi Shang has collaborated with scholars based in China and United States. Frequent co-authors include Shaoqiu Wu, Aiwu Mao, Bingyan Liu, Yiping Jia, Xiang Yin, Shuo Yan, Jun Ma, Jun Ma, Shu‐Heng Jiang and Xiaoxin Zhang. Their work appears in journals such as Cellular Signalling, Journal of Cellular Biochemistry, American Journal of Cancer Research, Journal of Cellular Physiology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.